Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Serotonin1A receptor density and serotonin concentration were measured in the postmortem neocortex of 17 AD patients who had been prospectively assessed every four months with the Mini-Mental State Examination (MMSE) for a mean of 2.6 years till death. In the frontal cortex, serotonin levels correlated negatively with the annual rate of MMSE decline, while serotonin1A receptor density was positively correlated with the rate of MMSE decline. Our study suggests that reduced serotonin levels and increased serotonin1A receptor density are markers for accelerated cognitive decline in AD, and provides support for the use of serotonin1A antagonists in the treatment of AD.


Journal article



Publication Date





1175 - 1178


8-Hydroxy-2-(di-n-propylamino)tetralin, Age Factors, Aged, Aged, 80 and over, Alzheimer Disease, Cognition Disorders, Disease Progression, Down-Regulation, Female, Humans, Male, Neocortex, Neurons, Neuropsychological Tests, Predictive Value of Tests, Radioligand Assay, Receptors, Serotonin, Receptors, Serotonin, 5-HT1, Serotonin, Serotonin Receptor Agonists, Sex Factors